In late May, Abilitech participated in The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) 2022 Symposium in collaboration with Children’s Hospital Los Angeles (CHLA).
A meaningful advocate amongst medical device communities, CTIP promotes the development, commercialization and use of assistive technology within the pediatric space. Its mission revolves around simultaneously engaging clinicians, engineers, regulators, hospital administrators, patients and businesses throughout all stages of device development.
With a theme of “Patient Impact, Patient Voice,” the 2022 symposium convened multiple stakeholders to highlight the growing need of patient voice within the medical device community. Panelists included CTIP-funded developers of pediatric medical devices, leaders from the FDA Office of Strategic Partnerships and Technology Innovation, and representatives from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).
Most notably, the symposium featured patients and families who discussed their daily-life experiences with medical devices, and how innovators such as Abilitech can incorporate their voice into device design and implementation.
Visit Health Tech Hot Spot for more about CTIP and its programming.
“Abilitech Medical is excited to collaborate with CTIP and provide industry perspectives,” said Abel Gueverra, Abilitech’s Vice President of Revenue Cycle and Market Access. “We continue to have open conversations with leaders in pediatric medical device design to incorporate innovative thinking into how we create inclusive designs for our patients.”